Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program
Abstract Background Patients with type 2 diabetes (T2D) are predisposed to derangements in serum Magnesium (Mg), which may have implications for cardiometabolic events and outcomes. In clinical trials, participants with T2D randomized to sodium‐glucose co‐transporter 2 (SGLT2) inhibitors have shown...
Shranjeno v:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2021-07-01
|
| Serija: | Endocrinology, Diabetes & Metabolism |
| Teme: | |
| Online dostop: | https://doi.org/10.1002/edm2.247 |
| Oznake: |
Brez oznak, prvi označite!
|